Ledger Run's CEO, John Chinnici, joins the Life Sciences Today Podcast to discuss how Ledger Run turns reliable, transparent site payments into a competitive advantage for sponsors.

February 6, 2026​

John Chinnici, CEO, makes the case that the greatest near-term ROI for AI in clinical research lies not in drug discovery, but in the operational bottlenecks slowing every trial today.

​

January 23, 2026

Ledger Run leaders predict that the greatest returns on AI investment in life sciences will be operational, not scientific, and they're available now.

​

January 5, 2026

In part 1 of his 3 part interview with Applied Clinical Trials, Kevin Williams explains why sponsors must evaluate sourcing models, systems, and automation together.

​

December 17, 2025

Sponsors who fail to address site payment and contracting friction risk losing access to the partners who make trials possible.​

​

October 22, 2025

Holly Leslie, VP of Services, explains how payment friction and AI-generated query burdens are pushing sites to become more selective

​

February 3, 2026

Industry leaders, including John Chinnici, make bold predictions for how AI will impact the Life Sciences industry in 2026​. 

​

January 7, 2026​​

In part 3 of his 3 part interview with Applied Clinical Trials, Kevin Williams offers a framework for evaluating how sourcing models, from full CRO outsourcing to functional service providers, directly shape site experience and study execution.

​

December 19, 2025

Kevin Williams contributes to ACRP's year-end roundup, emphasizing that AI must streamline site operations and enhance visibility without disrupting the daily flow of trial activities.

​

December 15, 2025

Ledger Run welcomes Patrick Mizer (CTO), Dennis Morgan (CFO), and Jody Quint (CCO) to its leadership team as the company enters its next phase of accelerated growth.

​

September 24, 2025

​Kevin Williams, CSO and EVP, examines how global trial complexity is reshaping the sponsor-CRO-site relationship and which operational models are proving most effective at scale.

​

January 29, 2026​​

Kevin Williams, CSO & EVP, predicts 2026 will finally be "the year of the site," with sponsors increasing investment in the support and empowerment of high performing research sites.

​

January 6, 2026

In part 2 of his 3 part interview with Applied clinical Trials, Kevin Williams examines how sponsors can introduce new tools without overwhelming sites.

​

December 18, 2025

Jenna Lucchesi, Executive Director of Contracts, calls 2026 the tipping point for rebuilding the clinical trial engine with real technology.

​

December 15, 2025